[{"Assets_0_Q2_USD":69308000.0,"CommonStockSharesOutstanding_0_Q2_shares":30660554.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-22862000.0,"NetIncomeLoss_1_Q2_USD":-10516000.0,"NetIncomeLoss_2_Q2_USD":-22207000.0,"StockholdersEquity_0_Q2_USD":39758000.0,"Ticker":"COGT","CIK":"1622229","name":"UNUM THERAPEUTICS INC.","OfficialName":"Cogent Biosciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"369716293.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190812"}]